CPK CHESAPEAKE UTILITIES
Permanent stock page ↗Utilities · Russell 2000
Next earnings: not announced yet
What 9 analyst firms say about CHESAPEAKE UTILITIES: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8024
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8054
Recent analyst activity · last 90 days
Our tracked history has 7 reports on CPK from 6 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 1 lowered it and 3 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Barclays lowered its target from $142.00 (set 21 Apr 2026) to $134.00 on 19 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Nicholas Campanella | Hold | 19 Oct 2026 | 134.00 USD |
| BTIG | Alex Kania | Hold | 26 Feb 2026 | — |
| Huntington | Unnamed analyst | Buy | 14 Sep 2026 | 150.00 USD |
| Ladenburg Thalmann | Paul Fremont | Buy | 15 Oct 2026 | 155.50 USD |
| Maxim Group | Tate Sullivan | Buy | 1 Jun 2026 | 160.00 USD |
| Mizuho | Gabriel Moreen | Buy | 11 Sep 2026 | 150.00 USD |
| Weiss Ratings | Unnamed analyst | — | 21 Oct 2026 | — |
| Wells Fargo | Constantine Lednev | Hold | 30 Sep 2026 | 136.00 USD |
| Data feed RESEARCH | Research Team | Hold | 21 May 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:47 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.